Overview

Phase III Study of Compound Danshen Dripping Pills to Treat Diabetic Retinopathy

Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of Compound Danshen Dripping Pills in patients with diabetic retinopathy(Syndrome Of Qi-Stagnation and Blood Stasis).
Phase:
Phase 3
Details
Lead Sponsor:
Tasly Pharmaceuticals, Inc.